Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | Agpat5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of AGPAT5 mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [APC protein affects the susceptibility to 1 and 2-Dimethylhydrazine] which results in increased expression of AGPAT5 mRNA | CTD | PMID:27840820 | 1,2-dimethylhydrazine | decreases expression | ISO | Agpat5 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of AGPAT5 mRNA | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in decreased expression of AGPAT5 mRNA | CTD | PMID:26496021 | 17beta-estradiol | increases expression | ISO | AGPAT5 (Homo sapiens) | 6480464 | Estradiol results in increased expression of AGPAT5 mRNA | CTD | PMID:31614463 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Agpat5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to AGPAT5 promoter] | CTD | PMID:19654925 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of AGPAT5 mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | AGPAT5 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of AGPAT5 mRNA | CTD | PMID:23152189 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Agpat5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of AGPAT5 mRNA | CTD | PMID:21570461 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of AGPAT5 mRNA | CTD | PMID:24780913 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of AGPAT5 mRNA | CTD | PMID:30047161 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of AGPAT5 mRNA | CTD | PMID:28959563 | all-trans-retinoic acid | decreases expression | ISO | AGPAT5 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of AGPAT5 mRNA | CTD | PMID:33167477 | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of AGPAT5 mRNA | CTD | PMID:30047161 | aristolochic acid A | decreases expression | ISO | AGPAT5 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of AGPAT5 mRNA | CTD | PMID:33212167 | arsenous acid | decreases expression | ISO | AGPAT5 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of AGPAT5 mRNA | CTD | PMID:26705709 | benzo[a]pyrene | increases expression | ISO | Agpat5 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of AGPAT5 mRNA | CTD | PMID:19770486 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | AGPAT5 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 | benzo[a]pyrene diol epoxide I | affects expression | ISO | AGPAT5 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:20382639 | bisphenol A | decreases expression | ISO | AGPAT5 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of AGPAT5 mRNA | CTD | PMID:20678512 | bisphenol A | decreases methylation | ISO | AGPAT5 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of AGPAT5 gene | CTD | PMID:31601247 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of AGPAT5 mRNA | CTD | PMID:25181051 more ... | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in decreased expression of AGPAT5 mRNA | CTD | PMID:26496021 | cadmium atom | multiple interactions | ISO | AGPAT5 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AGPAT5 mRNA | CTD | PMID:35301059 | cadmium dichloride | increases expression | ISO | Agpat5 (Mus musculus) | 6480464 | Cadmium Chloride results in increased expression of AGPAT5 mRNA | CTD | PMID:20883709 | cadmium dichloride | multiple interactions | ISO | AGPAT5 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AGPAT5 mRNA | CTD | PMID:35301059 | carbon nanotube | increases expression | ISO | Agpat5 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | chlorpyrifos | decreases expression | ISO | Agpat5 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of AGPAT5 mRNA | CTD | PMID:37019170 | chromium(6+) | affects expression | ISO | Agpat5 (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of AGPAT5 mRNA | CTD | PMID:28472532 | copper(II) sulfate | decreases expression | ISO | AGPAT5 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of AGPAT5 mRNA | CTD | PMID:19549813 | cyclosporin A | increases expression | ISO | AGPAT5 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of AGPAT5 mRNA | CTD | PMID:20106945 more ... | decabromodiphenyl ether | increases expression | EXP | | 6480464 | decabromobiphenyl ether results in increased expression of AGPAT5 mRNA | CTD | PMID:23640034 | diarsenic trioxide | decreases expression | ISO | AGPAT5 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of AGPAT5 mRNA | CTD | PMID:26705709 | dicrotophos | decreases expression | ISO | AGPAT5 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of AGPAT5 mRNA | CTD | PMID:28302478 | dioxygen | multiple interactions | ISO | Agpat5 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AGPAT5 mRNA | CTD | PMID:30529165 | ethanol | affects splicing | ISO | Agpat5 (Mus musculus) | 6480464 | Ethanol affects the splicing of AGPAT5 mRNA | CTD | PMID:30319688 | formaldehyde | decreases expression | ISO | AGPAT5 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of AGPAT5 mRNA | CTD | PMID:20655997 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of AGPAT5 mRNA | CTD | PMID:33387578 | hexadecanoic acid | multiple interactions | ISO | AGPAT5 (Homo sapiens) | 6480464 | [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of AGPAT5 mRNA | CTD | PMID:30547786 | ivermectin | decreases expression | ISO | AGPAT5 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of AGPAT5 protein | CTD | PMID:32959892 | lead(0) | affects splicing | ISO | AGPAT5 (Homo sapiens) | 6480464 | Lead affects the splicing of AGPAT5 mRNA | CTD | PMID:28903495 | leflunomide | decreases expression | ISO | AGPAT5 (Homo sapiens) | 6480464 | leflunomide results in decreased expression of AGPAT5 mRNA | CTD | PMID:28988120 | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of AGPAT5 mRNA | CTD | PMID:30047161 | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of AGPAT5 gene | CTD | PMID:35440735 | methyl methanesulfonate | decreases expression | ISO | AGPAT5 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of AGPAT5 mRNA | CTD | PMID:23649840 | methylparaben | increases expression | ISO | AGPAT5 (Homo sapiens) | 6480464 | methylparaben results in increased expression of AGPAT5 mRNA | CTD | PMID:31745603 | mitoxantrone | affects response to substance | ISO | AGPAT5 (Homo sapiens) | 6480464 | AGPAT5 protein affects the susceptibility to Mitoxantrone | CTD | PMID:16217747 | nickel atom | increases expression | ISO | AGPAT5 (Homo sapiens) | 6480464 | Nickel results in increased expression of AGPAT5 mRNA | CTD | PMID:25583101 | obeticholic acid | decreases expression | ISO | AGPAT5 (Homo sapiens) | 6480464 | obeticholic acid results in decreased expression of AGPAT5 mRNA | CTD | PMID:27939613 | oleic acid | multiple interactions | ISO | AGPAT5 (Homo sapiens) | 6480464 | [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of AGPAT5 mRNA | CTD | PMID:30547786 | paracetamol | decreases expression | ISO | AGPAT5 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of AGPAT5 mRNA | CTD | PMID:25704631 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of AGPAT5 mRNA | CTD | PMID:33387578 | paracetamol | increases expression | ISO | AGPAT5 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of AGPAT5 mRNA | CTD | PMID:29067470 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Agpat5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of AGPAT5 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of AGPAT5 mRNA | CTD | PMID:36331819 | pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of AGPAT5 mRNA | CTD | PMID:30047161 | propiconazole | increases expression | ISO | Agpat5 (Mus musculus) | 6480464 | propiconazole results in increased expression of AGPAT5 mRNA | CTD | PMID:21278054 | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of AGPAT5 mRNA | CTD | PMID:19013527 | sodium arsenite | increases expression | ISO | Agpat5 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of AGPAT5 mRNA | CTD | PMID:20883709 | sulfadimethoxine | increases expression | EXP | | 6480464 | Sulfadimethoxine results in increased expression of AGPAT5 mRNA | CTD | PMID:30047161 | tetrachloromethane | increases expression | ISO | Agpat5 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of AGPAT5 mRNA | CTD | PMID:31919559 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of AGPAT5 mRNA | CTD | PMID:23411599 and PMID:34492290 | Triptolide | increases expression | ISO | Agpat5 (Mus musculus) | 6480464 | triptolide results in increased expression of AGPAT5 mRNA | CTD | PMID:32835833 | tungsten | increases expression | ISO | Agpat5 (Mus musculus) | 6480464 | Tungsten results in increased expression of AGPAT5 mRNA | CTD | PMID:30912803 | urethane | decreases expression | ISO | AGPAT5 (Homo sapiens) | 6480464 | Urethane results in decreased expression of AGPAT5 mRNA | CTD | PMID:28818685 | valproic acid | decreases expression | ISO | AGPAT5 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of AGPAT5 mRNA | CTD | PMID:23179753 | valproic acid | increases expression | ISO | AGPAT5 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of AGPAT5 mRNA | CTD | PMID:28001369 and PMID:29154799 | valproic acid | affects expression | ISO | AGPAT5 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of AGPAT5 mRNA | CTD | PMID:25979313 | valproic acid | decreases methylation | ISO | AGPAT5 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of AGPAT5 gene | CTD | PMID:29154799 | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of AGPAT5 mRNA | CTD | PMID:23869203 | zoledronic acid | increases expression | ISO | AGPAT5 (Homo sapiens) | 6480464 | zoledronic acid results in increased expression of AGPAT5 mRNA | CTD | PMID:24714768 | |